{"answers":{"affected":"It affects 1 product.","exploited":"There is no known exploitation of CVE-2026-34324 in the wild and no public exploit code.","fix":"No fix has been published for CVE-2026-34324 yet. Limit exposure of the affected software until one is available.","what":"CVE-2026-34324 is a medium-severity missing authorization vulnerability in Oracle Life Sciences InForm, published on 21 Apr 2026. An attacker can exploit it over the internet without logging in, with no action from the victim."},"fix_prompt":"Check this codebase for CVE-2026-34324 and fix it if it is affected.\n\nWhat it is: CVE-2026-34324 is a medium-severity missing authorization vulnerability in Oracle Life Sciences InForm, published on 21 Apr 2026. An attacker can exploit it over the internet without logging in, with no action from the victim.\nExploitation: There is no known exploitation of CVE-2026-34324 in the wild and no public exploit code.\n\nAffected product: Oracle Life Sciences InForm. No package-level version data is available, so check the vendor advisory linked from the reference page.\n\nTask:\n1. Search the dependency manifests and lockfiles (for example package.json, package-lock.json, requirements.txt, poetry.lock, uv.lock, pom.xml, build.gradle, go.mod, Cargo.lock, Gemfile.lock) and any Dockerfiles for the affected packages, including transitive dependencies.\n2. If an affected version is in use, upgrade it to the fixed version for its release line with the project's package manager, so the lockfile is regenerated. Prefer the smallest upgrade that fixes it.\n3. If there is no fix, or the upgrade would break the build, do not guess: explain the risk and the safest workaround instead.\n4. Run the tests and summarise what changed and why.\n5. If nothing in the project is affected, say so and change nothing.\n\nReference: https://insights.sbomify.com/CVE-2026-34324/ (Markdown: https://insights.sbomify.com/CVE-2026-34324/index.md)","id":"CVE-2026-34324","markdown":"https://insights.sbomify.com/CVE-2026-34324/index.md","name":"CVE-2026-34324","record":{"aliases":["GHSA-cj86-2v89-gm24"],"analysis":{"component_type":"web_application","fix_type":"patch","impacts":["data_read","data_modify"],"network_reachable":"yes","non_default_config":false,"product_category":"Clinical Trial Management","requires_auth":"none","summary":"Unauthenticated attackers can read and modify clinical trial data via HTTP due to missing authorization checks in Oracle Life Sciences InForm.","user_interaction":"not_required","vuln_class":"missing_authorization"},"analysis_generated_by":"qwen3.8-flash-next","assigner":"oracle","cpe":[{"product":"life_sciences_inform","vendor":"oracle"}],"cvss":{"score":6.5,"severity":"medium","source":"cna","vector":"CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N","version":"3.1"},"cwes":[{"id":"CWE-284","name":"Improper Access Control"}],"description":"Vulnerability in the Oracle Life Sciences InForm product of Oracle Life Science Applications (component: App Server).  Supported versions that are affected are 7.0.1.0 and  7.0.1.1. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences InForm.  Successful attacks of this vulnerability can result in  unauthorized update, insert or delete access to some of Oracle Life Sciences InForm accessible data as well as  unauthorized read access to a subset of Oracle Life Sciences InForm accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts).  CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).","ecosystems":[],"exploits":{"exploitdb":0,"first_seen":null,"github_poc":0,"max_poc_stars":null,"metasploit":0,"nuclei":0,"refs":[],"tier":"none_known"},"has_fix":null,"headline":"Missing authorization in Oracle Life Sciences InForm","id":"CVE-2026-34324","indexable":true,"kev":null,"kind":"cve","links":{"ecosystem":null,"product":null,"products":[],"type":"missing_authorization","year":"2026"},"n_packages":0,"n_references":1,"next":{"headline":"Missing authorization in Oracle Financial Services Analytical Applications Infrastructure","id":"CVE-2026-34325"},"packages":[],"prev":{"headline":"Missing authorization in Oracle Life Sciences InForm","id":"CVE-2026-34323"},"products":["Oracle Life Sciences InForm"],"published":"2026-04-21","related":[{"cvss_score":6.3,"headline":"Missing authorization in Oracle Life Sciences InForm","id":"CVE-2026-34323","kev_date_added":null,"published":"2026-04-21"},{"cvss_score":6.1,"headline":"Missing authorization in Oracle Life Sciences InForm","id":"CVE-2025-62287","kev_date_added":null,"published":"2025-10-21"},{"cvss_score":4.3,"headline":"Information disclosure in Oracle Life Sciences InForm","id":"CVE-2025-61885","kev_date_added":null,"published":"2025-10-21"}],"sources":[{"class":"attribution","licence":"CVE Terms of Use (MITRE)","name":"CVE List","prefix":"CVE"},{"class":"attribution","licence":"US public information, NVD API terms","name":"NVD"},{"class":"attribution","licence":"CWE Terms of Use","name":"CWE (MITRE)"},{"class":"attribution","licence":"FIRST CVSS licence","name":"CVSS (FIRST)"}],"ssvc":{"automatable":"yes","exploitation":"none","technical_impact":"partial"},"state":"PUBLISHED","updated":"2026-04-22","vendors":["Oracle Corporation"]},"summary":"Unauthenticated attackers can read and modify clinical trial data via HTTP due to missing authorization checks in Oracle Life Sciences InForm.","url":"https://insights.sbomify.com/CVE-2026-34324/"}